Pyruvate kinase deficiency anaemia – Life with Disease

Go back

Pyruvate kinase deficiency anaemia is a rare genetic blood disorder that causes red blood cells to break down faster than the body can replace them. This lifelong condition affects people differently — some face severe challenges from birth, while others live relatively normal lives with symptoms appearing only during times of stress. Understanding what to expect and how to navigate daily life with this condition can help patients and families face the future with greater confidence.

Prognosis and Life Expectancy

The outlook for people living with pyruvate kinase deficiency varies significantly from person to person, making it difficult to predict exactly how the condition will affect any individual. This variation exists because the disease shows a wide spectrum of severity, ranging from life-threatening complications in newborns to mild symptoms that may not be noticed until adulthood.[1] For families hearing this diagnosis for the first time, it’s important to understand that this unpredictability is a defining feature of the condition, and each person’s journey will be unique.[2]

Many people with pyruvate kinase deficiency lead healthy, productive lives despite having the condition. Some individuals experience few or no symptoms and go undiagnosed well into adulthood, discovering their condition only when health events like pregnancy, infection or injury place extra stress on their bodies.[3] Children with mild disease often see their symptoms improve as they grow older, particularly after early childhood when the need for blood transfusions typically decreases.[4]

On the more severe end of the spectrum, some newborns face serious complications that require immediate lifesaving treatment, including regular blood transfusions throughout early childhood.[3] However, even in these more challenging cases, many patients can achieve a good quality of life with appropriate medical care and support. Statistics show that approximately 53% of children younger than five years require regular transfusions, but this drops to about 31% for children aged 5-12 years, suggesting that disease burden often lessens with age.[11]

Overall survival data suggest that most people with pyruvate kinase deficiency can expect to live into adulthood, though life expectancy may be somewhat reduced compared to the general population, particularly in more severe cases.[7] The availability of newer treatment options, including disease-modifying medications, offers hope for improved outcomes and quality of life for current and future patients.[17]

⚠️ Important
The severity of pyruvate kinase deficiency cannot always be predicted by genetic testing alone. Two people with the same genetic mutations may experience very different symptoms. This means that your healthcare team will need to monitor your individual response to the condition over time rather than relying solely on test results to predict your outlook.

Natural Progression Without Treatment

Understanding how pyruvate kinase deficiency develops when left untreated helps explain why medical care is so important. The condition is present from birth, even though symptoms may not appear immediately.[3] In the body, red blood cells normally live for about 120 days before being naturally broken down and replaced. However, in people with pyruvate kinase deficiency, red blood cells lack sufficient pyruvate kinase enzyme, which they need to produce energy in the form of adenosine triphosphate or ATP.[4]

Without adequate energy, these deficient red blood cells cannot maintain their shape and function properly. Instead of lasting the usual 120 days, they break down prematurely — sometimes surviving only a few days to weeks.[4] This premature destruction, called hemolysis, happens faster than the body can produce new red blood cells to replace them, resulting in chronic hemolytic anemia.[2]

As the body struggles to keep up with the loss of red blood cells, several processes occur naturally. The bone marrow attempts to compensate by producing red blood cells at a much faster rate than normal. This increased production requires significant energy and resources from the body, which can affect growth and development, particularly in children.[12] Young children with untreated severe anemia may experience slow growth, struggle with feeding, and have persistently low energy levels that prevent them from keeping up with their peers during play and exercise.[8]

The spleen, which is responsible for filtering damaged blood cells from circulation, works overtime in people with pyruvate kinase deficiency. Over time, this extra work causes the spleen to enlarge, a condition known as splenomegaly.[2] An enlarged spleen can be felt during physical examination and may cause discomfort or a feeling of fullness in the upper left side of the abdomen.

When red blood cells break down, they release several substances into the bloodstream. One of these substances is bilirubin, which causes yellowing of the skin and whites of the eyes, known as jaundice.[2] Another byproduct is iron, which accumulates in the body over time. Without proper management, this iron buildup can damage vital organs including the heart, liver and endocrine glands.[8] The excess bilirubin also increases the risk of developing gallstones, sometimes at surprisingly young ages.[2]

During times of physical stress — such as infections, pregnancy or injuries — the body’s demand for oxygen increases. For someone with pyruvate kinase deficiency, these periods can trigger more severe anemia as the already stressed system struggles even more to keep up with the body’s needs.[8] These episodes, sometimes called aplastic crises, can become medical emergencies requiring immediate attention.[8]

Possible Complications

Pyruvate kinase deficiency can lead to various complications that may develop over time, some of which can significantly impact health and wellbeing. Being aware of these potential problems helps patients and families recognize warning signs early and seek appropriate medical care.

Gallstones are among the most common complications, affecting many people with pyruvate kinase deficiency at some point in their lives. These small, pebble-like deposits form in the gallbladder or bile ducts due to the excess bilirubin released when red blood cells break down.[2] Gallstones can cause severe pain in the upper right abdomen, nausea and vomiting. In fact, among patients who undergo splenectomy, nearly half eventually require gallbladder removal (cholecystectomy) to address this complication.[11] Some doctors recommend removing the gallbladder at the same time as the spleen to prevent this problem later.

Iron overload, also called hemochromatosis, develops gradually in many patients with pyruvate kinase deficiency. This happens for two main reasons: the body naturally absorbs more iron from food when anemia is present, and regular blood transfusions introduce large amounts of iron into the body.[8] Over time, excess iron deposits in organs like the heart, liver and pancreas, potentially causing serious damage. Symptoms of iron overload might include fatigue, joint pain, abdominal pain and changes in skin color. Regular monitoring and treatment with iron-removing medications (chelation therapy) may be necessary for people receiving frequent transfusions.[11]

Blood clots represent another concerning complication that can occur in people with pyruvate kinase deficiency. The condition can increase the risk of thrombosis, where blood clots form in veins or arteries.[7] These clots can be dangerous if they travel to vital organs like the lungs, brain or heart. The exact reason why pyruvate kinase deficiency increases clotting risk isn’t fully understood, but it may relate to changes in blood flow and the presence of damaged red blood cells in circulation.

Leg ulcers can develop in some patients, particularly those with more severe disease. These are open sores on the lower legs that heal slowly and can be painful and prone to infection.[6] They occur because of poor oxygen delivery to the tissues and require careful wound care and sometimes specialized treatment.

Bone problems may emerge, particularly in patients with severe chronic anemia. The bone marrow expands significantly as it tries to produce more red blood cells, which can lead to changes in bone structure and increased fragility. A rare but serious complication is the development of masses of blood-forming tissue outside the bone marrow, called extramedullary hematopoiesis. These masses most commonly form along the spine and can compress nerves, causing pain, weakness or other neurological symptoms requiring urgent treatment.[7]

During pregnancy, women with pyruvate kinase deficiency face additional challenges. The increased demands on the body during pregnancy often worsen anemia, and hemoglobin levels may drop significantly.[11] Despite these challenges, successful pregnancies with healthy outcomes are possible with careful monitoring and management. However, increased jaundice after delivery and the potential need for blood transfusions during or after pregnancy are considerations that require planning with healthcare providers.[11]

Impact on Daily Life

Living with pyruvate kinase deficiency affects many aspects of daily life, though the degree of impact varies widely depending on how severe the condition is for each person. Understanding these potential effects can help patients and families develop strategies for managing challenges and maintaining quality of life.

Fatigue is perhaps the most commonly reported symptom that affects daily activities. This isn’t ordinary tiredness that improves with rest; rather, it’s a deep, persistent exhaustion that can make even simple tasks feel overwhelming.[5] Children may struggle to keep up with classmates during physical education or recess, often needing to sit out or take breaks. Adults might find it difficult to maintain full-time employment or keep up with household responsibilities. This chronic tiredness results from the body’s cells not receiving adequate oxygen due to the shortage of healthy red blood cells.[3]

Exercise intolerance is another significant challenge. Physical activities that others take for granted — climbing stairs, walking longer distances, playing sports — can trigger shortness of breath, rapid heartbeat and the need to stop and rest.[5] This limitation doesn’t mean people with pyruvate kinase deficiency cannot be active, but they often need to pace themselves carefully and choose activities that match their energy levels. For children and teenagers, this can affect social participation and self-esteem when they cannot engage fully in activities with friends.

Cognitive effects, including memory loss and difficulty concentrating, can impact school and work performance.[5] The brain requires a constant supply of oxygen to function optimally, and chronic anemia can affect mental clarity, attention span and the ability to process information quickly. Students may need extra support at school, such as additional time for tests or assignments, while adults might benefit from workplace accommodations.

The visible signs of the condition also affect daily life. Jaundice — the yellowing of skin and eyes — can be particularly distressing, especially for young people who may feel self-conscious about their appearance.[3] Paleness is another visible sign that might prompt repeated questions from others. Dark-colored urine, another symptom, can be alarming if unexpected.[8]

For patients requiring regular blood transfusions, frequent hospital visits can disrupt normal routines. Missing school or work, arranging transportation and spending hours at medical facilities becomes part of the regular schedule.[11] This not only takes time but can also create stress and interrupt important life activities.

The enlarged spleen common in pyruvate kinase deficiency creates practical limitations. Contact sports and activities with high risk of abdominal injury become dangerous because trauma to an enlarged spleen can cause life-threatening bleeding.[11] This restriction may disappoint athletic children and adults who must give up beloved activities.

Emotional and psychological impacts are also significant, though sometimes overlooked. Living with a chronic condition that causes persistent fatigue and requires ongoing medical management can lead to frustration, anxiety and sometimes depression. The unpredictability of symptom severity adds to this stress — not knowing when a particularly bad day might occur makes planning difficult. Social isolation can occur when energy limitations prevent participation in social activities or when the demands of medical care leave little time for normal social engagement.

Financial concerns represent another practical challenge. Even with insurance coverage, the costs of regular medical care, medications, transfusions and potential complications can accumulate. Families may need to consider factors like choosing employment based on health insurance coverage rather than career interests, or dealing with unexpected medical expenses from complications.

Despite these challenges, many people with pyruvate kinase deficiency develop effective coping strategies. Breaking tasks into smaller, manageable portions helps conserve energy. Planning important activities for times of day when energy tends to be highest allows for better participation. Building a strong support network of family, friends and healthcare providers creates a safety net for managing difficult periods. Open communication with employers or teachers about limitations and needs can lead to helpful accommodations.

⚠️ Important
People with pyruvate kinase deficiency often tolerate anemia better than might be expected based solely on their hemoglobin levels. This happens because the condition causes an increase in a substance called 2,3-diphosphoglycerate in red blood cells, which helps release oxygen to body tissues more efficiently. This is why doctors focus on managing symptoms rather than simply trying to achieve a particular hemoglobin number.

Support for Families

When a family member has pyruvate kinase deficiency, everyone is affected. Understanding how relatives can provide meaningful support and what families should know about clinical trials can make an important difference in managing this lifelong condition.

Clinical trials represent an important avenue of hope for people with pyruvate kinase deficiency. These research studies test new treatments to determine if they are safe and effective. For a condition as rare as pyruvate kinase deficiency, clinical trials are particularly valuable because they advance scientific understanding and may offer access to promising new therapies before they become widely available.[17] Recently, new medications that work by activating the pyruvate kinase enzyme have shown promise in helping patients produce healthier red blood cells, and these treatments emerged from clinical trial research.[17]

Families should understand that participating in a clinical trial is always voluntary, and deciding whether to participate is a deeply personal choice. Clinical trials have specific eligibility criteria — such as age ranges, disease severity, previous treatments received and specific genetic mutations — that determine who can enroll.[7] Not every patient will qualify for every trial, and this isn’t a reflection on the patient but rather the specific scientific questions the study aims to answer.

When considering clinical trial participation, families play a crucial role in gathering information and asking important questions. It’s helpful to understand what the study involves, including how often visits will be required, what tests will be performed, what the potential benefits and risks are, and what happens after the trial ends. Family members can assist by taking notes during discussions with research teams, helping the patient weigh the pros and cons, and providing practical support like transportation to study visits.

Finding appropriate clinical trials requires some detective work. Healthcare providers, particularly specialists in blood disorders (hematologists), often know about relevant studies. Patient advocacy organizations and disease registries maintain lists of active trials. Online databases like ClinicalTrials.gov allow families to search for pyruvate kinase deficiency studies by location and eligibility criteria.[4] Some families find it helpful to periodically check these resources, as new trials open regularly.

Preparation for clinical trial participation involves practical considerations where family support proves invaluable. Organizing medical records, compiling a complete medication history, documenting symptom patterns and coordinating schedules for study visits requires time and attention to detail. Family members can help by creating organized files of medical information, keeping calendars of appointments, and ensuring the patient doesn’t miss important study-related activities.

Beyond clinical trials, families provide essential day-to-day support in numerous ways. Emotional support matters enormously — simply being present, listening without judgment, and acknowledging the challenges of living with a chronic condition helps patients feel less alone. Family members can educate themselves about pyruvate kinase deficiency to better understand what their loved one experiences and to recognize warning signs of complications that require medical attention.

Practical assistance takes many forms. Helping with household tasks when fatigue is overwhelming, accompanying the patient to medical appointments, assisting with medication management, and providing transportation to receive transfusions all make daily life more manageable. For children with the condition, parents might need to communicate with schools about necessary accommodations, monitor activity levels to prevent overexertion, and advocate for their child’s needs in various settings.

Family members can also help connect patients with support resources. Patient advocacy groups specifically focused on pyruvate kinase deficiency offer valuable connections with others facing similar challenges. Online communities allow people to share experiences, coping strategies and emotional support with others who truly understand. Disease registries not only contribute to research but also help patients stay informed about new developments and treatment options.[7]

Genetic counseling services provide important support for families as well. Because pyruvate kinase deficiency follows an autosomal recessive inheritance pattern, family members who appear healthy might carry one copy of the mutated gene.[2] Understanding inheritance patterns helps families make informed decisions about genetic testing for relatives and future family planning. Genetic counselors can explain complex genetic information in understandable terms and discuss options available to families.

Maintaining family relationships requires attention and care when chronic illness is present. Siblings of children with pyruvate kinase deficiency may feel overlooked when parents focus significant attention on the ill child’s medical needs. Partners of adults with the condition may feel helpless watching their loved one struggle with fatigue and symptoms. Open communication, counseling when needed, and making time for relationships beyond the medical aspects of the condition help maintain family bonds.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Mitapivat (Pyrukynd) – An oral pyruvate kinase activator that works by allosterically binding to pyruvate kinase enzyme and increasing its activity. Approved by the US FDA in February 2022 for treatment of adults with hemolytic anemia due to pyruvate kinase deficiency.

Ongoing Clinical Trials on Pyruvate kinase deficiency anaemia

  • Study on the Effectiveness and Safety of Mitapivat for Children with Pyruvate Kinase Deficiency Receiving Regular Blood Transfusions

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark The Netherlands Spain
  • Study on Gene Therapy for Pyruvate Kinase Deficiency Using Autologous CD34+ Cells in Adults and Children

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Spain
  • Study on the Effectiveness and Safety of Mitapivat in Children with Pyruvate Kinase Deficiency Not Receiving Regular Blood Transfusions

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Spain
  • Study on Long-Term Safety of Gene Therapy for Pyruvate Kinase Deficiency Using Autologous CD34+ Cells in Adults and Children

    Not recruiting

    1 1 1
    Investigated diseases:
    Spain

References

https://www.ncbi.nlm.nih.gov/books/NBK560581/

https://medlineplus.gov/genetics/condition/pyruvate-kinase-deficiency/

https://my.clevelandclinic.org/health/diseases/23419-pyruvate-kinase-deficiency

https://www.childrenshospital.org/conditions/pk-deficiency

https://www.agios.com/rare-diseases/pyruvate-kinase-deficiency/

https://en.wikipedia.org/wiki/Pyruvate_kinase_deficiency

https://haematologica.org/article/view/9854

https://kidshealth.org/en/parents/pyruvate-kinase-deficiency.html

https://my.clevelandclinic.org/health/diseases/23419-pyruvate-kinase-deficiency

https://pubmed.ncbi.nlm.nih.gov/30681718/

https://emedicine.medscape.com/article/2196589-treatment

https://kidshealth.org/en/parents/pyruvate-kinase-deficiency.html

https://pubmed.ncbi.nlm.nih.gov/32702739/

https://my.clevelandclinic.org/health/diseases/23419-pyruvate-kinase-deficiency

https://www.knowpkdeficiency.com/patient-caregiver-resources-and-support

https://www.childrenshospital.org/conditions/pk-deficiency

https://pmc.ncbi.nlm.nih.gov/articles/PMC11417781/

https://kidshealth.org/en/parents/pyruvate-kinase-deficiency.html

https://thewaitingroom.karger.com/tell-me-about/treating-pyruvate-kinase-deficiency-managing-the-anemia/

https://pkdguidelines.org/

FAQ

Can pyruvate kinase deficiency be cured?

Pyruvate kinase deficiency is a genetic condition present from birth that lasts a lifetime. While it cannot currently be cured, it can be managed with various treatments. Emerging therapies like mitapivat offer disease-modifying treatment that can improve red blood cell survival and reduce symptoms. Hematopoietic stem cell transplantation has been reported in isolated cases but is not considered standard therapy due to risks and incomplete engraftment.

Will my child with pyruvate kinase deficiency be able to attend school normally?

Most children with pyruvate kinase deficiency can attend school, though some may need accommodations depending on symptom severity. Common needs include extra time for assignments and tests due to fatigue or concentration difficulties, permission to rest when tired, restrictions from contact sports if the spleen is enlarged, and flexibility for frequent medical appointments. Communication between parents, teachers and healthcare providers helps ensure appropriate support is in place.

Does pyruvate kinase deficiency get worse with age?

Pyruvate kinase deficiency often improves rather than worsens as children grow older. Many children who require regular blood transfusions in early childhood need them less frequently as they age. Symptoms in adults often remain stable for long periods, though they may temporarily worsen during times of physical stress such as infections or pregnancy. Each person’s experience is different, making regular monitoring by a hematologist important.

Can women with pyruvate kinase deficiency have healthy pregnancies?

Yes, women with pyruvate kinase deficiency can have successful pregnancies and healthy babies, though pregnancy requires careful medical monitoring. Anemia often worsens during pregnancy as the body’s demands increase, and hemoglobin levels may drop significantly. Some women experience increased jaundice after delivery. With close monitoring by both hematology and obstetric specialists, most women can safely carry pregnancies to term, though blood transfusions may be needed during or after delivery.

If I have pyruvate kinase deficiency, will my children have it too?

Pyruvate kinase deficiency follows an autosomal recessive inheritance pattern, meaning you need two copies of the mutated gene (one from each parent) to have the condition. If both you and your partner carry at least one mutated gene, there is a 25% chance with each pregnancy that your child will have the condition. Genetic counseling can help you understand your specific situation and discuss options for genetic testing and family planning.

🎯 Key takeaways

  • Pyruvate kinase deficiency causes a spectrum of disease severity, meaning two people with the same genetic mutations may have completely different experiences with symptoms and complications.
  • Most people with this condition tolerate lower hemoglobin levels better than expected because their red blood cells release oxygen more efficiently to body tissues.
  • Children with pyruvate kinase deficiency often see their symptoms improve with age, with transfusion needs typically decreasing as they grow older.
  • Symptoms often worsen during times of physical stress such as infections, pregnancy or injuries when the body’s oxygen demands increase.
  • Nearly half of patients who undergo splenectomy eventually require gallbladder removal due to gallstone complications, which is why some doctors recommend removing both organs together.
  • The recent approval of mitapivat represents the first disease-modifying medication for pyruvate kinase deficiency, offering new hope for symptom management beyond supportive care.
  • Approximately 300 different genetic mutations can cause pyruvate kinase deficiency, making genetic testing both valuable and sometimes complex to interpret.
  • Regular monitoring is essential because complications like iron overload, blood clots and extramedullary hematopoiesis can develop gradually over time without obvious early warning signs.